Drug Discovery And Early-Stage Biopharma companies

Mirae Asset Capital Life Science was formed in 2023 as a joint venture between Mirae Asset Capital and Mirae Asset Global Investments. It is the first and only…

Curie.Bio is a unique combination of two businesses: we act as both your drug discovery copilot & seed investor. We have some of the world’s best drug hunte…

Our expertise in biopharma and biotech investments. With decades of experience and a robust network within the biopharma and biotech industries, our team offers…

Claris Ventures SGR is a venture capital firm based in Italy, founded in 2019. Its first fund under management, Claris Biotech I, is focused on early stage inve…

Cambrian Biopharma, a multi-asset longevity biotech, is building the medicines that will redefine healthcare in the 21st century – therapeutics to lengthen heal…

We support the development of novel medicines that address significant unmet medical needs. As co-investors, you will find us straight forward, transparent, lon…

Aditum Bio brings together unmatched scientific and domain expertise with agile operational capabilities. Our unique investment and operating model enables rapi…

Since 2006 we’ve backed Yale faculty doing cutting edge research on some of the world’s largest problems. With Yale as our largest investor, we’ve supported tea…

Amgen Ventures has made >70 INVESTMENTS placing >$400M of the $625M Amgen has committed to support healthcare innovation and interconnectivity at all stag…

At StartUp Health, we are impact-driven entrepreneurs and investors building a global army of thousands of Health Transformers collaborating to achieve health m…

Trinity Innovation Bioventure Singapore is a licensed biomed venture capital fund focusing on innovation and value investment with deep insight and experience o…

The journey from discovery to medical breakthrough demands imagination, speed, and focus. At Mission BioCapital, we provide early-stage capital to the next gene…

Our primary focus is on the development of novel therapeutics and platforms. In our investments we look for unmet need and clinical impact, novel proprietary sc…

SCI Ventures is a novel, evergreen fund created to catalyze innovative cures for paralysis. Backed by the leading foundations for spinal cord injury in the US a…

Bioluminescence Ventures is a biotechnology venture firm investing in Drug Discovery Platforms (Oncology, Immunology, Neuroscience, Genetic Diseases), Applied B…

We are Lumira Ventures. $450M+ Invested: Over more than two decades, our firm has invested over $1B via multiple investment funds. $70B+ Cumulative Revenue of P…

We are a European family office owned fund; we understand biosciences and medical technologies better than anyone else in the Private Equity and Venture Capital…

Earlybird is a venture capital investor focused on European technology innovators. Founded in 1997, Earlybird invests in all development and growth phases of te…

Our portfolio includes companies at all stages of development, from early-stage companies testing transformative technologies to commercial-stage companies seek…

AdBio partners (formerly Advent France Biotechnology) is a venture capital firm investing in early stage life sciences companies in Europe. AdBio partners’ uniq…